Edition:
India

Netscientific PLC (NSCI.L)

NSCI.L on London Stock Exchange

7.00GBp
14 Oct 2019
Change (% chg)

-- (--)
Prev Close
7.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
47,877
52-wk High
29.90
52-wk Low
1.00

Latest Key Developments (Source: Significant Developments)

Netscientific Says Its Core Portfolio Companies Have Continued To Make Good Progress During H1
Thursday, 19 Sep 2019 

Sept 19 (Reuters) - Netscientific PLC ::NETSCIENTIFIC PLC - INTERIM RESULTS FOR SIX MONTHS ENDED 30 JUNE 2019.NETSCIENTIFIC PLC - GROUP'S CORE PORTFOLIO COMPANIES HAVE CONTINUED TO MAKE GOOD PROGRESS DURING FIRST HALF OF 2019.NETSCIENTIFIC PLC - FOCUS OF GROUP DURING SECOND HALF OF 2019 WILL BE TO CONTINUE TO REALISE VALUE IN INVESTMENTS IN AN ORDERLY MANNER..  Full Article

Netscientific's Glycotest Receives $3 Mln Initial Tranche From Fosun Pharma
Thursday, 14 Feb 2019 

Feb 14 (Reuters) - Netscientific PLC ::NETSCIENTIFIC PLC - GLYCOTEST INC. RECEIVES $3 MILLION INITIAL TRANCHE FROM $10 MILLION SERIES A FINANCING.NETSCIENTIFIC PLC - GLYCOTEST INC. HAS RECEIVED INITIAL $3M TRANCHE OF $10M SERIES A FINANCING ROUND WITH SHANGHAI FOSUN PHARMACEUTICAL CO.  Full Article

PDS, Edge Therapeutics Enter Into Merger Agreement to Form Cancer Immunotherapy Co
Monday, 26 Nov 2018 

Nov 26 (Reuters) - Netscientific PLC ::NETSCIENTIFIC - PDS BIOTECHNOLOGY ENTERS MERGER AGREEMENT WITH EDGE THERAPEUTICS TO FORM NASDAQ-LISTED CLINICAL-STAGE CANCER IMMUNOTHERAPY CO.NETSCIENTIFIC PLC - PDS ANNOUNCES MERGER WITH EDGE THERAPEUTICS.NETSCIENTIFIC PLC - ALL-SHARE MERGER BETWEEN PDS AND EDGE THERAPEUTICS IS EXPECTED TO CREATE A COMBINED COMPANY.NETSCIENTIFIC PLC - COMBINED COMPANY PLANS TO INITIATE MULTIPLE PHASE 2B/3 CLINICAL TRIALS OF PDS0101 IN HPV-ASSOCIATED CANCERS.NETSCIENTIFIC - AFTER MERGER, FORMER PDS SHAREHOLDERS WILL OWN ABOUT 70% OF COMBINED CO & EXISTING EDGE SHAREHOLDERS WILL OWN ABOUT 30% OF COMBINED CO.NETSCIENTIFIC - PDS, EDGE THERAPEUTICS COMBINATION TO HAVE SUFFICIENT CASH ON HAND TO START MULTIPLE LATE-STAGE CLINICAL STUDIES FOR PDS0101.NETSCIENTIFIC PLC - PDS, EDGE THERAPEUTICS MERGER WILL OPERATE UNDER PDS BIOTECHNOLOGY CORPORATION NAME AFTER DEAL.NETSCIENTIFIC PLC - NETSCIENTIFIC IS EXPECTED TO OWN 9.17% OF PDS BIOTECHNOLOGY ON A FULLY-DILUTED BASIS.  Full Article

Netscientific Reports HY Loss After Tax Of 4.6 Mln Stg
Friday, 28 Sep 2018 

Sept 28 (Reuters) - Netscientific PLC ::NETSCIENTIFIC PLC - HY LOSS AFTER TAX OF £4.6M (H1 2017: LOSS £5.2M).  Full Article

Netscientific Says Two New Patents Exclusively Licensed To Wanda
Tuesday, 12 Dec 2017 

Dec 12 (Reuters) - Netscientific Plc ::ANNOUNCES ISSUE BY U.S. PATENT AND TRADEMARK OFFICE OF TWO NEW PATENTS EXCLUSIVELY LICENSED TO ITS PORTFOLIO COMPANY, WANDA.  Full Article